Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.
from NYT > Health https://ift.tt/5wHTx9S
via IFTTT
from NYT > Health https://ift.tt/5wHTx9S
via IFTTT

No comments